Cutaneous manifestations in renal transplant recipients;Renal transplantasyon hastalarinda gözlenen deri bulgulari

Turkderm Deri Hastaliklari ve Frengi Arsivi

Volumn 42, Issue 1, 2008, Pages 18-21

  Demirgüneş, Fatma Elif ^a   Evans, Sibel Ersoy ^a   Yilmaz, Rahmi ^b   Şahin, Sedef ^a   Yasavul, Ünal ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Ic Hastaliklari Anabilim Dali   (Turkey)

Author keywords

Immunosupressive therapy; Renal transplantation

Indexed keywords

AZATHIOPRINE;

ACNE; ACTINIC KERATOSIS; ADULT; ARTICLE; BASAL CELL CARCINOMA; CHICKENPOX; CONTROLLED STUDY; DERMATOMYCOSIS; FEMALE; FOLLICULITIS; GRAFT RECIPIENT; HERPES SIMPLEX; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MOLLUSCUM CONTAGIOSUM; POSTOPERATIVE PERIOD; PREVALENCE; SKIN CULTURE; SKIN EXAMINATION; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; TINEA VERSICOLOR; VERRUCA VULGARIS;

EID: 51849161254     PISSN: 1019214X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-12.
2. Moloney FJ, Keane S, O'Kelly P, et al. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol 2005; 153: 574-8.
3. Lugo-Janer G, Sanchez JL, Santiago-Delphin E. Prevalence and clinical spectrum of skin diseases in kidney transplant recipients. J Am Acad Dermatol 1991; 24: 410-4.
4. Hampton T. Skin cancer's ranks rise: immunosuppression to blame. JAMA 2005; 294: 1476-80.
5. Barba A, Tessari G, Boschiero L, et al. Renal transplantation and skin diseases: review of the literature and results of a 5-year follow-up of 285 patients. Nephron 1996; 73: 131-6.
6. Seckin D, Gulec TO, Demirag A, et al. Renal transplantation and skin diseases. Transplant Proc 1998; 30: 802-4.
7. McLelland J, Rees A, Williams G, et al. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 1988; 46: 871-4.
8. Alper S, Kilinc I, Duman S, et al. Skin diseases in Turkish renal transplant recipients. Int J Dermatol 2005;44:939-41.
9. Vijayakumar R, Fernando E, Rajendran S, et al. Dermatological manifestations in renal transplant recipients. Transplant Proc 1998; 30: 3136.
10. Haim S, Friedman-Birnbaum R, Better OS, et al. Skin complications in immunosuppressed patients: follow-up of kidney recipients. Br J Dermatol 1973; 89: 169-73.
11. Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989;21;1:124-8.
12. Dyall-Smith D, Trowell H, Dyall-Smith ML. Benign human papillomavirus infection in renal transplant recipients. Int J Dermatol 1991;30:785-9.
13. Sontheimer RD, Bergstresser PR, Gailiunas P Jr, et al. Perturbation of epidermal Langerhans cells in immunosuppressed human renal allograft recipients. Transplantation 1984;37:168-74.
14. Harwood CA, Surentheran T, Sasieni P, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004;150: 949-57.
15. Formicone F, Fargnoli MC, Pisani F, et al. Cutaneous manifestations in Italian kidney transplant recipients. Transplant Proc 2005; 37: 2527-8.
16. Taşkapan O, Şener O, Yenicesu M, ve ark. Renal transplantli olgularda deri bulgularinin deǧerlendirilmesi. Diyaliz, Transplantasyon ve Yanik (Başkent Üniversitesi Tip Bilimleri Dergisi) 1995; 8:27-31.
17. Moloney FJ, de Freitas D, Conlon PJ, et al. Renal transplantation, immunosuppression and the skin: an update. Photodermatol Photoimmunol Photomed 2005;21:1-8.
18. Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-9.
19. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146:1-6.
20. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-91.
21. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309:1871-4.
22. Hiesse C, Larue JR, Kriaa P, et al. Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients. Transplant Proc 1995;27:2450-1.
23. Blohme I, Larkoe O. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy. Acta Derm Venereol (Stockh) 1990;70:491-4.
24. Bunney MH, Benton EC, Barr BB, et al. The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine. Nephrol Dial Transplant 1990;5:379-82.
25. Ulrich C, Stockfleth E. Azathioprine, UV light, and skin cancer in organ transplant patients-do we have an answer? Nephrol Dial Transplant 2007;22:1027-9.